Technical Analysis for ORGOW - Organogenesis Holdings Inc. Warrants

Grade Last Price % Change Price Change
grade B 0.55 61.76% 0.2100
ORGOW closed up 61.76 percent on Thursday, August 29, 2019, on 0 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
See historical ORGOW trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 61.76%
Wide Bands Range Expansion 61.76%
Older signals for ORGOW ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Medicine Diabetes Surgery Regenerative Medicine Sports Medicine Wound Wound Care Products Ulcer Diabetic Foot Ulcers Venous Ulcer Diabetic Foot Ulcer Medicine Products Surgical Treatment Venous Leg Ulcers Surgical Applications

Is ORGOW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.75
52 Week Low 0.1503
Average Volume 119,652
200-Day Moving Average 0.0000
50-Day Moving Average 0.4303
20-Day Moving Average 0.4265
10-Day Moving Average 0.3930
Average True Range 0.0477
ADX 17.42
+DI 52.4251
-DI 31.6018
Chandelier Exit (Long, 3 ATRs ) 0.4069
Chandelier Exit (Short, 3 ATRs ) 0.4431
Upper Bollinger Band 0.5489
Lower Bollinger Band 0.3041
Percent B (%b) 1.0
BandWidth 57.3974
MACD Line -0.0083
MACD Signal Line -0.0110
MACD Histogram 0.0027
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.5500
Resistance 3 (R3) 0.5500 0.5500 0.5500
Resistance 2 (R2) 0.5500 0.5500 0.5500 0.5500
Resistance 1 (R1) 0.5500 0.5500 0.5500 0.5500 0.5500
Pivot Point 0.5500 0.5500 0.5500 0.5500 0.5500
Support 1 (S1) 0.5500 0.5500 0.5500 0.5500 0.5500
Support 2 (S2) 0.5500 0.5500 0.5500 0.5500
Support 3 (S3) 0.5500 0.5500 0.5500
Support 4 (S4) 0.5500